Sermorelin & GHRP-2 Blend
A research blend of sermorelin and GHRP-2, combining GHRH pathway activation with ghrelin receptor stimulation for potent synergistic GH release.
Community Rating
No ratings yet
⚠ Research & Educational Use Only. Sermorelin & GHRP-2 Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Potent synergistic GH pulse amplitude
- Complementary dual-receptor mechanism
- Strong IGF-1 elevation for body composition research
- Sermorelin & GHRP-2 Blend is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Potent synergistic GH pulse amplitude
- Complementary dual-receptor mechanism
- Strong IGF-1 elevation for body composition research
- Well-characterized in human and animal studies
What is Sermorelin & GHRP-2 Blend?
Tap any underlined term for an instant definition.
Sermorelin & GHRP-2 Blend combines the GHRH analogue sermorelin with the potent ghrelin-mimetic GHRP-2. This blend is one of the most studied GH-stimulating peptide combinations, with documented human pharmacokinetic data showing synergistic GH pulse amplification and sustained IGF-1 elevation.
What It Is
- Sermorelin (GHRH 1-29): stimulates GHRHR on pituitary somatotrophs
- GHRP-2: binds GHS-R1a with high potency, suppresses somatostatin, produces stronger GH response than ipamorelin but with some cortisol/prolactin elevation
- Combined for synergistic GH axis stimulation
- GHRP-2 preferred where maximum GH output is the research goal (vs ipamorelin for cleaner profile)
How It Works
- Dual receptor activation: sermorelin via GHRHR + GHRP-2 via GHS-R1a
- Somatostatin suppression by GHRP-2 removes the negative feedback loop simultaneously
- Combined GH pulse amplitude: 3-5x each peptide alone in most studies
- Example: GHRH 1-29 + GHRP-2 combination produced GH peaks of 40-60 ng/mL vs 10-15 ng/mL for sermorelin alone in multiple published studies
Key Research Findings
- Human GH response: GH pulse amplitudes 3-5x either peptide alone
- IGF-1: 65-85% increase from baseline at 3 months daily administration
- Body composition: Studies with this combination report 2-3.5 kg lean mass increase and 3-4% fat mass reduction at 6 months
Dosing From the Literature
- Sermorelin 200-300 mcg + GHRP-2 100-200 mcg per injection
- Keep GHRP-2 below 300 mcg to minimize cortisol elevation
- Once daily at bedtime or twice daily
Storage and Handling
- Lyophilised: 2-8 degrees C; 24 months
- Reconstituted: 2-8 degrees C; use within 30 days
Key Research Benefits
Documented effects observed in preclinical and clinical studies on Sermorelin & GHRP-2 Blend. See all Peptide Blends peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Subcutaneous injection, best on empty stomach at bedtime or pre-sleep.
Explore Further
Quick Reference
More in Peptide Blends
- Sermorelin & Ipamorelin Blend
- Sermorelin & GHRP-6 Blend
- Sermorelin & GHRP-6 & GHRP-2 Triple Blend
- Tesamorelin & Ipamorelin Blend
Research Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.